Click to login and read the full article.
Don’t have access? Click here to request a demo
Alternatively, Call a member of the team to discuss membership options
US and Overseas: +1 646-931-9045
UK: 0207 139 1600
Abstract
Aging populations, the drive for better preventive medicines, and the increasing reliance on the private sector to help societies pay for ballooning healthcare costs continue to make healthcare a prized sector, with returns higher than in most other industries. That’s as true in Europe as it is elsewhere in the world. Yet private equity participation in the region remains stubbornly low. Private equity firms have struggled to find attractive opportunities due to the fragmented and patchwork nature of European healthcare markets as well as strong competition between investors. The authors’ latest report examines how private equity can increase its presence in the European healthcare market.
TOPICS: Private equity, developed, other real assets, portfolio construction
- © 2017 Institutional Investor, LLC
Don’t have access? Click here to request a demo
Alternatively, Call a member of the team to discuss membership options
US and Overseas: +1 646-931-9045
UK: 0207 139 1600